April 1, 2013

Lotus Clinical Research will be presenting a Scientific Poster at the American Pain Society’s 32nd Annual Scientific Meeting May 8-11 in New Orleans, LA entitled “A systematic review of the sensitivity of efficacy endpoints TOTPAR and SPID in acute pain”. Poster will be available on May 8^th, 2013.

April 1, 2013

The Clinical Trials SIG will discuss “Reducing the Risk of Failure in Analgesic Clinical Trials,” with presentations by Nathaniel Katz, MD MS, and Neil Singla, MD. Dr. Nathaniel Katz will discuss “An Evidence-Based Approach to Improving Assay Sensitivity in Clinical Trials” and Dr. Neil Singla will discuss “Applying the Principles of Improved Assay Sensitivity in Analgesic Drug Development.”

Click here for more information on the upcoming APS Meeting

July 1, 2012

Neil Singla, MD, Founder & Chief Scientific Officer, Lotus Clinical Research, LLC will be giving a presentation entitled “Minimizing experimental error in analgesic research by reducing placebo response and variability” at the 6^th Annual Pain Therapeutics Summit. Read full story

April 6, 2012

Lotus Clinical Research will be presenting a Scientific Poster at the American Pain Society’s 31st Annual Scientific Meeting May 16-19 in Honolulu, Hawaii entitled “Decreasing the number of clinical centers involved in an analgesic trial may increase the effect size and reduce the probability of a false negative” Click here to view poster presented at APS 2012

April 6, 2012

The Clinical Trials SIG will discuss “Reducing the Risk of Failure in Analgesic Clinical Trials,” with presentations by Nathaniel Katz, MD MS, and Neil Singla, MD. Dr. Nathaniel Katz will discuss “An Evidence-Based Approach to Improving Assay Sensitivity in Clinical Trials” and Dr. Neil Singla will discuss “Applying the Principles of Improved Assay Sensitivity in Analgesic Drug Development.” Click here for more information on the upcoming APS Meeting: